Physician profile
Francisco Antonio Perez Loreto
NPI 1033547856
$16,691.75
in general payments reported to CMS, 2019-2025
11 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $167 · 2023: $281 · 2024: $769 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $2,003 · Food and Beverage: $1,798 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,455.00 |
| Travel and Lodging | $2,003.36 |
| Food and Beverage | $1,797.71 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $12,599.26 | 2025 | |
| Medical Device Business Services, INC. | $2,598.30 | 2024-2025 | Vistaseal, Harmonic |
| Ethicon US, LLC | $521.58 | 2023-2025 | Vistaseal, Echelon Endopath, Echelon; Endopath |
| Davol INC. | $486.35 | 2022-2024 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $141.06 | 2025 | |
| Conmed Corporation | $131.80 | 2021 | |
| Ets Wound Care LLC | $92.96 | 2024 | Mirragen Advanced Wound Matrix |
| Becton, Dickinson and Company | $74.28 | 2024 | Phasix Mesh |
| Organogenesis INC. | $19.94 | 2025 | Puraply Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $13.22 | 2022 | |
| Lifenet Health | $13.00 | 2025 | Pliafx Flo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Perez Loreto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.